Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

The Small RNA Repertoire of Small Extracellular Vesicles Isolated From Donor Kidney Preservation Fluid Provides a Source for Biomarker Discovery for Organ Quality and Posttransplantation Graft Function.

Gremmels H, de Jong OG, Toorop RJ, Michielsen L, van Zuilen AD, Vlassov AV, Verhaar MC, van Balkom BWM.

Transplant Direct. 2019 Aug 12;5(9):e484. doi: 10.1097/TXD.0000000000000929. eCollection 2019 Sep.

2.

Validation of randomized controlled trial-derived models for the prediction of postintervention outcomes in chronic limb-threatening ischemia.

Wijnand JGJ, van Koeverden ID, Teraa M, Spreen MI, Mali WPTM, van Overhagen H, Pasterkamp G, de Borst GJ, Conte MS, Gremmels H, Verhaar MC.

J Vasc Surg. 2019 Sep 26. pii: S0741-5214(19)31790-2. doi: 10.1016/j.jvs.2019.06.195. [Epub ahead of print]

PMID:
31564582
3.

Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets.

van de Wouw J, Broekhuizen M, Sorop O, Joles JA, Verhaar MC, Duncker DJ, Danser AHJ, Merkus D.

Front Physiol. 2019 Sep 4;10:1108. doi: 10.3389/fphys.2019.01108. eCollection 2019. Review.

4.

Reactivity of (Vicinal) Carbonyl Compounds with Urea.

Jong JAW, Smakman R, Moret ME, Verhaar MC, Hennink WE, Gerritsen KGF, Van Nostrum CF.

ACS Omega. 2019 Jul 10;4(7):11928-11937. doi: 10.1021/acsomega.9b01177. eCollection 2019 Jul 31.

5.

Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease.

Eisenga MF, Emans ME, van der Putten K, Cramer MJ, Diepenbroek A, Velthuis BK, Doevendans PA, Verhaar MC, Joles JA, Bakker SJL, Nolte IM, Braam B, Gaillard CAJM.

J Am Heart Assoc. 2019 Aug 20;8(16):e011130. doi: 10.1161/JAHA.118.011130. Epub 2019 Aug 17.

6.

Geriatric Assessment and the Relation with Mortality and Hospitalizations in Older Patients Starting Dialysis.

van Loon IN, Goto NA, Boereboom FTJ, Bots ML, Hoogeveen EK, Gamadia L, van Bommel EFH, van de Ven PJG, Douma CE, Vincent HH, Schrama YC, Lips J, Siezenga MA, Abrahams AC, Verhaar MC, Hamaker ME.

Nephron. 2019;143(2):108-119. doi: 10.1159/000501277. Epub 2019 Aug 13.

7.

Applicability of Transcutaneous Oxygen Tension Measurement in the Assessment of Chronic Limb-Threatening Ischemia.

Leenstra B, Wijnand J, Verhoeven B, Koning O, Teraa M, Verhaar MC, de Borst GJ.

Angiology. 2019 Aug 6:3319719866958. doi: 10.1177/0003319719866958. [Epub ahead of print]

PMID:
31387360
8.

Indoxyl Sulfate Stimulates Angiogenesis by Regulating Reactive Oxygen Species Production via CYP1B1.

Pei J, Juni R, Harakalova M, Duncker DJ, Asselbergs FW, Koolwijk P, Hinsbergh VV, Verhaar MC, Mokry M, Cheng C.

Toxins (Basel). 2019 Aug 2;11(8). pii: E454. doi: 10.3390/toxins11080454.

9.

Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction.

Brandt MM, Nguyen ITN, Krebber MM, van de Wouw J, Mokry M, Cramer MJ, Duncker DJ, Verhaar MC, Joles JA, Cheng C.

J Cell Mol Med. 2019 Oct;23(10):6666-6678. doi: 10.1111/jcmm.14542. Epub 2019 Jul 31.

10.

A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia.

Gremmels H, Teraa M, de Jager SCA, Pasterkamp G, de Borst GJ, Verhaar MC.

Sci Rep. 2019 Jul 24;9(1):10740. doi: 10.1038/s41598-019-47217-1.

11.

Remote sensing and signaling in kidney proximal tubules stimulates gut microbiome-derived organic anion secretion.

Jansen J, Jansen K, Neven E, Poesen R, Othman A, van Mil A, Sluijter J, Sastre Torano J, Zaal EA, Berkers CR, Esser D, Wichers HJ, van Ede K, van Duursen M, Burtey S, Verhaar MC, Meijers B, Masereeuw R.

Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):16105-16110. doi: 10.1073/pnas.1821809116. Epub 2019 Jul 24.

12.

Direct Comparison of the Thickness Of The Parietal Peritoneum Using Peritoneal Biopsy and Ultrasonography of the Abdominal Wall in Patients Treated with Peritoneal Dialysis.

Abrahams AC, Dendooven A, van der Veer JW, Wientjes R, Toorop RJ, Bleys RLAW, Hendrickx APA, van Leeuwen MS, de Lussanet QG, Verhaar MC, Stapper G, Nguyen TQ.

Perit Dial Int. 2019 Sep-Oct;39(5):455-464. doi: 10.3747/pdi.2018.00108. Epub 2019 Jul 23.

PMID:
31337699
13.

[The wearable artificial kidney: what is the current state of play?]

Wester M, van Gelder MK, Joles JA, Verhaar MC, Kooman JP, Gerritsen KGF.

Ned Tijdschr Geneeskd. 2019 Jul 4;163. pii: D3728. Dutch.

PMID:
31283124
14.

Association of Initiation of Maintenance Dialysis with Functional Status and Caregiver Burden.

Goto NA, van Loon IN, Boereboom FTJ, Emmelot-Vonk MH, Willems HC, Bots ML, Gamadia LE, van Bommel EFH, Van de Ven PJG, Douma CE, Vincent HH, Schrama YC, Lips J, Hoogeveen EK, Siezenga MA, Abrahams AC, Verhaar MC, Hamaker ME.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1039-1047. doi: 10.2215/CJN.13131118. Epub 2019 Jun 27.

PMID:
31248948
15.

Thoracic vertebral fractures and hyperkyphosis in elderly patients with end-stage kidney disease; do these patients have different clinical outcomes?

Goto NA, Koelé MC, van Loon IN, Boereboom FTJ, Verhaar MC, Emmelot-Vonk MH, Hamaker ME, Willems HC.

Bone. 2019 Oct;127:181-187. doi: 10.1016/j.bone.2019.06.007. Epub 2019 Jun 11.

PMID:
31200077
16.

Antibodies against ARHGDIB are associated with long-term kidney graft loss.

Kamburova EG, Gruijters ML, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Melchers RCA, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Bemelman FJ, Otten HG.

Am J Transplant. 2019 Jun 13. doi: 10.1111/ajt.15493. [Epub ahead of print]

PMID:
31194283
17.

Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.

Heidt S, Haasnoot GW, Witvliet MD, van der Linden-van Oevelen MJH, Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Otten HG, Roelen DL, Claas FHJ.

Am J Transplant. 2019 Oct;19(10):2926-2933. doi: 10.1111/ajt.15486. Epub 2019 Jul 1.

18.

Exhaustion of the bone marrow progenitor cell reserve is associated with major events in severe limb ischemia.

Gremmels H, van Rhijn-Brouwer FCC, Papazova DA, Fledderus JO, Teraa M, Verhaar MC; JUVENTAS study group.

Angiogenesis. 2019 Aug;22(3):411-420. doi: 10.1007/s10456-019-09666-0. Epub 2019 Mar 30.

19.
20.

Tubuloids derived from human adult kidney and urine for personalized disease modeling.

Schutgens F, Rookmaaker MB, Margaritis T, Rios A, Ammerlaan C, Jansen J, Gijzen L, Vormann M, Vonk A, Viveen M, Yengej FY, Derakhshan S, de Winter-de Groot KM, Artegiani B, van Boxtel R, Cuppen E, Hendrickx APA, van den Heuvel-Eibrink MM, Heitzer E, Lanz H, Beekman J, Murk JL, Masereeuw R, Holstege F, Drost J, Verhaar MC, Clevers H.

Nat Biotechnol. 2019 Mar;37(3):303-313. doi: 10.1038/s41587-019-0048-8. Epub 2019 Mar 4.

PMID:
30833775
21.

Histological characteristics of Acute Tubular Injury during Delayed Graft Function predict renal function after renal transplantation.

Pieters TT, Falke LL, Nguyen TQ, Verhaar MC, Florquin S, Bemelman FJ, Kers J, Vanhove T, Kuypers D, Goldschmeding R, Rookmaaker MB.

Physiol Rep. 2019 Mar;7(5):e14000. doi: 10.14814/phy2.14000.

22.

Effect of donor variation on osteogenesis and vasculogenesis in hydrogel cocultures.

Pennings I, van Dijk LA, van Huuksloot J, Fledderus JO, Schepers K, Braat AK, Hsiao EC, Barruet E, Morales BM, Verhaar MC, Rosenberg AJWP, Gawlitta D.

J Tissue Eng Regen Med. 2019 Mar;13(3):433-445. doi: 10.1002/term.2807. Epub 2019 Feb 8.

23.

Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients.

Kamburova EG, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Meeldijk J, Bovenschen N, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Front Immunol. 2018 Dec 19;9:3002. doi: 10.3389/fimmu.2018.03002. eCollection 2018.

24.

Performance of bleeding risk scores in dialysis patients.

Ocak G, Ramspek C, Rookmaaker MB, Blankestijn PJ, Verhaar MC, Bos WJW, Dekker FW, van Diepen M.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1223-1231. doi: 10.1093/ndt/gfy387.

PMID:
30608543
25.

Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.

Michielsen LA, van Zuilen AD, Verhaar MC, Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Hilbrands LB.

Nephrol Dial Transplant. 2018 Dec 15. doi: 10.1093/ndt/gfy377. [Epub ahead of print]

PMID:
30561730
26.

Author Correction: Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0099-y.

PMID:
30538326
27.

Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis.

Vervoort SJ, de Jong OG, Roukens MG, Frederiks CL, Vermeulen JF, Lourenço AR, Bella L, Vidakovic AT, Sandoval JL, Moelans C, van Amersfoort M, Dallman MJ, Bruna A, Caldas C, Nieuwenhuis E, van der Wall E, Derksen P, van Diest P, Verhaar MC, Lam EW, Mokry M, Coffer PJ.

Elife. 2018 Dec 3;7. pii: e27706. doi: 10.7554/eLife.27706.

28.

Coronary Artery Calcification in Hemodialysis and Peritoneal Dialysis.

Jansz TT, van Reekum FE, Özyilmaz A, de Jong PA, Boereboom FTJ, Hoekstra T, Verhaar MC, van Jaarsveld BC.

Am J Nephrol. 2018;48(5):369-377. doi: 10.1159/000494665. Epub 2018 Nov 13.

29.

Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.

de Jong OG, van der Waals LM, Kools FRW, Verhaar MC, van Balkom BWM.

J Cell Physiol. 2019 Jul;234(7):10260-10269. doi: 10.1002/jcp.27695. Epub 2018 Nov 1.

30.

Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease.

Goto NA, van Loon IN, Morpey MI, Verhaar MC, Willems HC, Emmelot-Vonk MH, Bots ML, Boereboom FTJ, Hamaker ME.

Nephron. 2019;141(1):41-48. doi: 10.1159/000494222. Epub 2018 Nov 1.

31.

A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.

Michielsen LA, Wisse BW, Kamburova EG, Verhaar MC, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, van Zuilen AD.

Nephrol Dial Transplant. 2019 Jun 1;34(6):1056-1063. doi: 10.1093/ndt/gfy316.

PMID:
30365008
32.

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30361677
33.

Accidental falling in community-dwelling elderly with chronic kidney disease.

Goto NA, Hamaker ME, Willems HC, Verhaar MC, Emmelot-Vonk MH.

Int Urol Nephrol. 2019 Jan;51(1):119-127. doi: 10.1007/s11255-018-1992-9. Epub 2018 Oct 15.

34.

Health-related quality of life compared between kidney transplantation and nocturnal hemodialysis.

Jansz TT, Bonenkamp AA, Boereboom FTJ, van Reekum FE, Verhaar MC, van Jaarsveld BC.

PLoS One. 2018 Sep 20;13(9):e0204405. doi: 10.1371/journal.pone.0204405. eCollection 2018.

35.

Bioengineering Organs for Blood Detoxification.

Legallais C, Kim D, Mihaila SM, Mihajlovic M, Figliuzzi M, Bonandrini B, Salerno S, Yousef Yengej FA, Rookmaaker MB, Sanchez Romero N, Sainz-Arnal P, Pereira U, Pasqua M, Gerritsen KGF, Verhaar MC, Remuzzi A, Baptista PM, De Bartolo L, Masereeuw R, Stamatialis D.

Adv Healthc Mater. 2018 Nov;7(21):e1800430. doi: 10.1002/adhm.201800430. Epub 2018 Sep 19. Review.

PMID:
30230709
36.

The role of kidney transplantation and phosphate binder use in vitamin K status.

Jansz TT, Neradova A, van Ballegooijen AJ, Verhaar MC, Vervloet MG, Schurgers LJ, van Jaarsveld BC.

PLoS One. 2018 Aug 30;13(8):e0203157. doi: 10.1371/journal.pone.0203157. eCollection 2018.

37.

A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol.

van Rhijn-Brouwer FCC, Gremmels H, Fledderus JO, Schuurman AH, Bonte-Mineur F, Vonk MC, Voskuyl AE, de Vries-Bouwstra JK, Coert JH, Radstake TRDJ, van Laar JM, Verhaar MC; MANUS Study Group.

BMJ Open. 2018 Aug 20;8(8):e020479. doi: 10.1136/bmjopen-2017-020479.

38.

Toward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival.

Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Stephan Sanders J, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Transplantation. 2019 Apr;103(4):789-797. doi: 10.1097/TP.0000000000002357.

39.

CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions.

Chrifi I, Louzao-Martinez L, Brandt MM, van Dijk CGM, Bürgisser PE, Zhu C, Kros JM, Verhaar MC, Duncker DJ, Cheng C.

Angiogenesis. 2019 Feb;22(1):75-93. doi: 10.1007/s10456-018-9638-1. Epub 2018 Aug 10.

40.

Cell Therapy for Chronic Limb-Threatening Ischemia: Current Evidence and Future Directions.

Teraa M, Gremmels H, Wijnand JGJ, Verhaar MC.

Stem Cells Transl Med. 2018 Dec;7(12):842-846. doi: 10.1002/sctm.18-0025. Epub 2018 Aug 1.

41.

Mortality due to bleeding, myocardial infarction and stroke in dialysis patients.

Ocak G, Noordzij M, Rookmaaker MB, Cases A, Couchoud C, Heaf JG, Jarraya F, De Meester J, Groothoff JW, Waldum-Grevbo BE, Palsson R, Resic H, Remón C, Finne P, Stendahl M, Verhaar MC, Massy ZA, Dekker FW, Jager KJ.

J Thromb Haemost. 2018 Oct;16(10):1953-1963. doi: 10.1111/jth.14254. Epub 2018 Aug 22.

PMID:
30063819
42.

Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.

43.

Dissecting recipient from donor contribution in experimental kidney transplantation: focus on endothelial proliferation and inflammation.

Papazova DA, Krebber MM, Oosterhuis NR, Gremmels H, van Zuilen AD, Joles JA, Verhaar MC.

Dis Model Mech. 2018 Jul 17;11(7). pii: dmm035030. doi: 10.1242/dmm.035030.

44.

Removal of urea by electro-oxidation in a miniature dialysis device: a study in awake goats.

Wester M, van Gelder MK, Joles JA, Simonis F, Hazenbrink DHM, van Berkel TWM, Vaessen KRD, Boer WH, Verhaar MC, Gerritsen KGF.

Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1385-F1397. doi: 10.1152/ajprenal.00094.2018. Epub 2018 Jul 11.

45.

Is progression of coronary artery calcification influenced by modality of renal replacement therapy? A systematic review.

Jansz TT, Verhaar MC, London GM, van Jaarsveld BC.

Clin Kidney J. 2018 Jun;11(3):353-361. doi: 10.1093/ckj/sfx124. Epub 2017 Oct 26.

46.

Mesenchymal Stromal Cell Characteristics and Regenerative Potential in Cardiovascular Disease: Implications for Cellular Therapy.

van Rhijn-Brouwer FCC, Gremmels H, Fledderus JO, Verhaar MC.

Cell Transplant. 2018 May;27(5):765-785. doi: 10.1177/0963689717738257. Epub 2018 Jun 13. Review.

47.

Vitamin K antagonist use and renal function in pre-dialysis patients.

Voskamp PW, Dekker FW, Rookmaaker MB, Verhaar MC, Bos WJW, van Diepen M, Ocak G.

Clin Epidemiol. 2018 May 29;10:623-630. doi: 10.2147/CLEP.S154719. eCollection 2018.

48.

Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.

Michielsen LA, van Zuilen AD, Kardol-Hoefnagel T, Verhaar MC, Otten HG.

Front Immunol. 2018 May 14;9:972. doi: 10.3389/fimmu.2018.00972. eCollection 2018.

49.

Endothelial loss of Fzd5 stimulates PKC/Ets1-mediated transcription of Angpt2 and Flt1.

Brandt MM, van Dijk CGM, Chrifi I, Kool HM, Bürgisser PE, Louzao-Martinez L, Pei J, Rottier RJ, Verhaar MC, Duncker DJ, Cheng C.

Angiogenesis. 2018 Nov;21(4):805-821. doi: 10.1007/s10456-018-9625-6. Epub 2018 May 29.

50.

Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia.

van Haelst STW, Teraa M, Moll FL, de Borst GJ, Verhaar MC, Conte MS.

J Vasc Surg. 2018 Oct;68(4):1104-1113.e1. doi: 10.1016/j.jvs.2018.02.028. Epub 2018 May 22.

PMID:
29802042

Supplemental Content

Loading ...
Support Center